Analysis published 21 Jun 2026

AI-generated · cited to primary sources · not investment advice

IZMO (532341) Feb 2026 Filing Analysis

01 · Management Credibility

Does management do what it says?

MetProcess Maturity and Certification
85/100

The company reiterates its commitment to an average annual R&D spend of Rs. 10-12 cr, which remains >10% of its revenue base. (1 met across 1 tracked commitment)

Strong R&D Initiatives: Average annual spend of Rs. 10-12 cr (>10% of revenue)

IZMO · Investor PPT · Feb 2026 · p.20
In progressIndia's BPM Market Growing at 7.9% Domestically
60/100

For 9M FY26, revenue from operations reached Rs. 175.72 cr compared to Rs. 164.80 cr in 9M FY25, representing a growth of 6.63%. This is currently tracking below the full-year target of 20-30%. (1 in progress across 1 tracked commitment)

Total Income from Operations 175.72 164.80 6.63%

IZMO · Investor PPT · Feb 2026 · p.14

See the full cited Management analysis of IZMO

Create free account →
02 · Business Model

How durable is the business?

Multi-Shore Delivery Model Optimization
80/100

North America continues to be the dominant geographic market, increasing its revenue share to 72% from the previously noted 59%. (1 expanding)

North America 72% (By Geography Q3 FY26)

IZMO · Investor PPT · Feb 2026 · p.12

See the full cited Business Model analysis of IZMO

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.